DEAD/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 9 (DHX9) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
DHX9 Antibody is a Goat Polyclonal antibody against DHX9.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | DEAD/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 9 (DHX9) |
| Host | Goat |
| Reactivity | Human |
| Recommended Dilution | P-ELISA: 1/16000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Size 1 | 200 µl |
| Form | Liquid |
| Tested Applications | P-ELISA, WB |
| Buffer | Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 1660, 13211, 304859 |
| NCBI Accession | NP_001348.2 |
| Background | Antibody anti-DHX9 |
| Status | RUO |
| Note | Concentration: 0.5 mg/ml - |
Descripción
Related Products
DHX9 antibody
Unwinds double-stranded DNA and RNA in a 3' to 5' direction. Alteration of secondary structure may subsequently influence interactions with proteins or other nucleic acids. Functions as a transcriptional activator. Component of the CRD-mediated complex that promotes MYC mRNA stability. Involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2. As component of a large PER complex is involved in the inhibition of 3' transcriptional termination of circadian target genes such as PER1 and NR1D1 and the control of the circadian rhythms. Positively regulates HIV-1 LTR-directed gene expression.
Ver Producto
Recombinant Human DHX9
Ver Producto
DEAD/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 9 (DHX9) Antibody
Unwinds double-stranded DNA and RNA in a 3' to 5' direction. Alteration of secondary structure may subsequently influence interactions with proteins or other nucleic acids. Functions as a transcriptional activator. Component of the CRD-mediated complex that promotes MYC mRNA stability. Involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2.
Ver Producto